Insomnia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Insomnia stocks.

Insomnia Stocks Recent News

Date Stock Title
May 2 NBIX Neurocrine Biosciences Inc (NBIX) Q1 2024 Earnings: Strong Revenue Growth and Strategic Advancements
May 1 NBIX Neurocrine Q1 revenue beats Street, gets FDA okay for Ingrezza Sprinkle
May 1 NBIX Neurocrine Biosciences, Inc. (NBIX) Q1 2024 Earnings Call Transcript
May 1 NBIX Why Things Are Looking Up For IBD Stock Of The Day Neurocrine, A Top 1% Biotech
May 1 ITCI Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?
May 1 NBIX Neurocrine (NBIX) Reports Q1 Earnings: What Key Metrics Have to Say
May 1 NBIX Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates
May 1 NERV Minerva Neurosciences GAAP EPS of -$1.13
May 1 NERV Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
May 1 NBIX Neurocrine Biosciences Non-GAAP EPS of $1.20 misses by $0.09, revenue of $515.3M beats by $3.29M
May 1 NBIX Neurocrine Biosciences Reports First Quarter 2024 Financial Results
Apr 30 NBIX UPDATE 2-Neurocrine Biosciences' Huntington's disease drug gets FDA approval
Apr 30 NBIX Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules
Apr 30 VNDA Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
Apr 30 NBIX Neurocrine Biosciences Q1 2024 Earnings Preview
Apr 30 NBIX Curious about Neurocrine (NBIX) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Apr 30 ITCI Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast
Apr 30 MNOV MediciNova (NASDAQ:MNOV) investors are sitting on a loss of 89% if they invested five years ago
Apr 30 ITCI Intra-Cellular Therapies: Positive MDD Data And Commercial Momentum Make It A Buy
Apr 25 NBIX Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data
Insomnia

Insomnia, also known as sleeplessness, is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood. It may result in an increased risk of motor vehicle collisions, as well as problems focusing and learning. Insomnia can be short term, lasting for days or weeks, or long term, lasting more than a month.Insomnia can occur independently or as a result of another problem. Conditions that can result in insomnia include psychological stress, chronic pain, heart failure, hyperthyroidism, heartburn, restless leg syndrome, menopause, certain medications, and drugs such as caffeine, nicotine, and alcohol. Other risk factors include working night shifts and sleep apnea. Diagnosis is based on sleep habits and an examination to look for underlying causes. A sleep study may be done to look for underlying sleep disorders. Screening may be done with two questions: "do you experience difficulty sleeping?" and "do you have difficulty falling or staying asleep?"Sleep hygiene and lifestyle changes are typically the first treatment for insomnia. Sleep hygiene includes a consistent bedtime, exposure to sunlight, a quiet and dark room, and regular exercise. Cognitive behavioral therapy may be added to this. While sleeping pills may help, they are associated with injuries, dementia, and addiction. These medications are not recommended for more than four or five weeks. The effectiveness and safety of alternative medicine is unclear.Between 10% and 30% of adults have insomnia at any given point in time and up to half of people have insomnia in a given year. About 6% of people have insomnia that is not due to another problem and lasts for more than a month. People over the age of 65 are affected more often than younger people. Females are more often affected than males. Descriptions of insomnia occur at least as far back as ancient Greece.

Browse All Tags